Trademark: 88622881
Word
NXACT
Status
Registered
Status Code
700
Status Date
Tuesday, October 12, 2021
Serial Number
88622881
Registration Number
6521401
Registration Date
Tuesday, October 12, 2021
Mark Type
4000
Filing Date
Thursday, September 19, 2019
Published for Opposition
Tuesday, December 15, 2020

Trademark Owner History
Nurix Therapeutics, Inc. - Original Registrant

Classifications
5 Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
42 Research and development in the pharmaceutical and biotechnology fields
NX ACT

Trademark Events
Oct 12, 2021
Registered-Principal Register
Sep 9, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 8, 2021
Allowed Principal Register - Sou Accepted
Aug 9, 2021
Statement Of Use Processing Complete
Jul 29, 2021
Use Amendment Filed
Aug 9, 2021
Case Assigned To Intent To Use Paralegal
Jul 29, 2021
Teas Statement Of Use Received
Feb 9, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 15, 2020
Official Gazette Publication Confirmation E-Mailed
Dec 15, 2020
Published For Opposition
Nov 25, 2020
Notification Of Notice Of Publication E-Mailed
Nov 10, 2020
Approved For Pub - Principal Register
Nov 5, 2020
Suspension Checked - To Attorney For Action
Nov 4, 2020
Assigned To Lie
Mar 9, 2020
Notification Of Letter Of Suspension E-Mailed
Mar 9, 2020
Letter Of Suspension E-Mailed
Mar 9, 2020
Suspension Letter Written
Mar 9, 2020
Examiner's Amendment Entered
Mar 9, 2020
Notification Of Examiners Amendment E-Mailed
Mar 9, 2020
Examiners Amendment E-Mailed
Mar 9, 2020
Examiners Amendment -Written
Dec 26, 2019
Notification Of Non-Final Action E-Mailed
Dec 26, 2019
Non-Final Action E-Mailed
Dec 26, 2019
Non-Final Action Written
Dec 19, 2019
Assigned To Examiner
Sep 25, 2019
New Application Office Supplied Data Entered
Sep 23, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24